# What are the current adrenal insufficiency testing protocols in 2026?

Lily Armstrong · September 5, 2026

> Direct Answer: The Current Standard for Adrenal Insufficiency Testing The definitive approach to adrenal insufficiency testing protocols in 2026...

## Direct Answer: The Current Standard for Adrenal Insufficiency Testing

The definitive approach to adrenal insufficiency testing protocols in 2026 centers on dynamic stimulation assays rather than isolated morning cortisol measurements. Clinicians now prioritize the high-dose (250 microgram) synthetic adrenocorticotropic hormone (ACTH) stimulation test as the primary screening tool for primary adrenal insufficiency, while the low-dose (1 microgram) ACTH stimulation test and insulin tolerance test remain reserved for specific clinical scenarios or secondary/tertiary evaluation. The diagnostic workflow has shifted toward a tiered methodology that integrates baseline serum cortisol, plasma renin activity, aldosterone levels, and ACTH concentrations before proceeding to stimulation challenges. This structured sequence reduces false-positive results and minimizes unnecessary glucocorticoid exposure during the diagnostic window. Modern guidelines emphasize that a single resting cortisol value lacks the sensitivity required to rule out adrenal dysfunction, particularly when symptoms present atypically or overlap with other endocrine disorders. Laboratories have standardized assay calibration using liquid chromatography-tandem mass spectrometry (LC-MS/MS), which has improved inter-laboratory consistency and reduced measurement drift across different healthcare networks. Patients presenting with fatigue, hypotension, hyperpigmentation, or unexplained electrolyte abnormalities undergo this sequential protocol to confirm or exclude adrenal pathology before initiating long-term replacement therapy.

**Also worth reading:** [What are the current early COPD screening guidelines and how should patients approach testing?](https://healtho.io/knowledge/what_are_the_current_early_copd_screening_guidelines_and_how_should_patients_approach_testing.php) · [What are the definitive post-ICU metabolic monitoring protocols for recovering patients?](https://healtho.io/knowledge/what_are_the_definitive_post-icu_metabolic_monitoring_protocols_for_recovering_patients.php) · [What are the definitive pediatric imaging AI validation standards and how do they differ from adult protocols?](https://healtho.io/knowledge/what_are_the_definitive_pediatric_imaging_ai_validation_standards_and_how_do_they_differ_from_adult_protocols.php)

## How the Testing Protocol Works Step by Step

The diagnostic pathway begins with obtaining fasting blood samples to measure baseline morning cortisol, typically drawn between 8:00 AM and 9:00 AM to capture the circadian peak. Simultaneous plasma ACTH, sodium, potassium, and renin-aldosterone ratios are collected to differentiate primary from secondary etiologies. If baseline cortisol falls below 3 micrograms per deciliter, clinicians often initiate immediate stress-dose steroids without waiting for stimulation results, recognizing that severe deficiency requires urgent intervention. For indeterminate baseline values ranging from 3 to 15 micrograms per deciliter, the standard 250 mcg cosyntropin injection is administered intravenously or intramuscularly. Cortisol levels are then measured at thirty and sixty minutes post-injection. A peak cortisol concentration exceeding 18 to 20 micrograms per deciliter generally excludes primary adrenal insufficiency with high confidence. When the response blunts below this threshold, further evaluation targets the hypothalamic-pituitary axis. Secondary adrenal insufficiency presents differently because the adrenal glands retain structural integrity but lack trophic stimulation. In these cases, the low-dose 1 mcg ACTH test offers greater sensitivity for detecting subtle pituitary dysfunction, though it remains technically demanding due to precise dilution requirements. Some centers also employ the metyrapone test or overnight dexamethasone suppression test to assess corticotroph reserve, particularly when autoimmune or infiltrative diseases complicate the clinical picture. The entire sequence typically spans two to three clinic visits over several weeks to allow washout periods if prior steroid use interferes with assay accuracy.

## Why Dynamic Stimulation Tests Replace Static Measurements

Static cortisol readings fail to capture the adaptive capacity of the hypothalamic-pituitary-adrenal axis under physiological stress. The adrenal cortex operates as a responsive organ system that must rapidly synthesize and release glucocorticoids when confronted with infection, surgery, or metabolic demand. A resting blood draw only documents basal secretion, which naturally fluctuates throughout the day and can appear normal even when reserve capacity is severely compromised. Dynamic stimulation tests deliberately challenge the axis to reveal hidden deficits that static sampling misses. Research published through 2025 demonstrated that up to thirty percent of patients with suspected secondary adrenal insufficiency exhibit normal morning cortisol levels despite inadequate stress responses. The high-dose ACTH test directly evaluates zona fasciculata function by bypassing upstream regulatory pathways. If the adrenal glands cannot mount an appropriate cortisol surge after exogenous ACTH administration, primary failure is confirmed. Conversely, a preserved response to high-dose stimulation combined with a blunted response to low-dose dosing points toward central dysfunction. This physiological differentiation guides treatment selection, since primary deficiency requires both glucocorticoid and mineralocorticoid replacement, whereas secondary deficiency typically involves glucocorticoid therapy alone. The shift away from isolated laboratory values reflects a broader movement toward functional assessment in endocrinology, ensuring that diagnoses align with actual glandular performance rather than snapshot chemistry.

## Practical Steps for Patients Navigating the Diagnostic Process

Patients preparing for adrenal insufficiency testing should coordinate closely with their prescribing physician to manage concurrent medications that interfere with cortisol metabolism. Oral contraceptives, estrogen therapy, and certain anticonvulsants alter cortisol-binding globulin concentrations, which skews total cortisol measurements. Switching to non-hormonal alternatives or adjusting timing before blood draws improves assay reliability. Individuals taking chronic glucocorticoids must follow a supervised tapering schedule before stimulation testing begins, as exogenous steroids suppress endogenous production and produce falsely negative results. Fasting is generally recommended for four to six hours prior to baseline sampling to minimize gastrointestinal interference, though water intake remains permitted. Patients should arrive at the laboratory rested and avoid strenuous exercise within twenty-four hours, since physical exertion artificially elevates cortisol and masks underlying deficiency. During the ACTH stimulation visit, individuals typically receive the injection in one arm while serial venipunctures occur in the opposite arm at designated intervals. Bringing a light snack helps prevent vasovagal reactions, and scheduling the procedure early in the morning aligns with natural circadian rhythms. Follow-up appointments review integrated results alongside clinical history, allowing physicians to correlate laboratory data with symptom patterns. Telehealth platforms increasingly support pre-test counseling and post-result interpretation, reducing travel burden while maintaining diagnostic rigor. Documentation of all prior steroid exposures, including topical formulations and intra-articular injections, remains essential for accurate test selection and result interpretation.

## Comparison of Primary Versus Secondary Adrenal Insufficiency Testing Pathways

| Feature | Primary Adrenal Insufficiency Testing | Secondary Adrenal Insufficiency Testing |
| --- | --- | --- |
| Baseline Biomarkers | Low cortisol, high ACTH, hyponatremia, hyperkalemia, elevated renin | Low/normal cortisol, low/normal ACTH, normal electrolytes |
| First-Line Stimulation Test | 250 mcg cosyntropin IV/IM bolus | 1 mcg cosyntropin IV or 250 mcg IM depending on protocol |
| Expected Peak Response | Blunted (

Canonical: https://healtho.io/knowledge/what_are_the_current_adrenal_insufficiency_testing_protocols_in_2026.php
Markdown: https://healtho.io/knowledge/what_are_the_current_adrenal_insufficiency_testing_protocols_in_2026.php/index.md